Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069923 · ClinicalTrials.gov registry record · NA
OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04069923: Completed NA study, sponsored by Jonsson Comprehensive Cancer Center.
NCT04069923 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04069923, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This trial studies the side effects of OsteoCrete in filling bone voids in participants with bone voids or defects. OsteoCrete may eliminate the need for further surgery and the removal of healthy bone.
Interventions
- OTHER Magnesium-based Bone Void Filler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2022-01-17 |
| Phase | NA |
What the finished NCT04069923 record still lists
NCT04069923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Magnesium-based Bone Void Filler is the first listed.
NCT04069923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04069923 about?
NCT04069923 is a clinical study titled "OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects". This trial studies the side effects of OsteoCrete in filling bone voids in participants with bone voids or defects. OsteoCrete may eliminate the need for further surgery and the removal of healthy bone.
What is the current status of trial NCT04069923?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-12-18. Estimated completion is 2022-01-17.
What interventions are being tested in trial NCT04069923?
The interventions under investigation include: Magnesium-based Bone Void Filler (OTHER).
Who is sponsoring clinical trial NCT04069923?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04069923's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI